Dr. Schwebke’s laboratory has emphasized microbiologic studies of vaginal flora in women including Trichomonas vaginalis and bacterial vaginosis (BV). Dr. Schwebke’s recent work has included the development of new methodologies for evaluation of changes in vaginal flora over time, new perspectives on the origins and management of women with BV, and evaluation of new diagnostic tests (culture methods, PCR) for trichomoniasis. She has also recently guided development of laboratory efforts to evaluate and carry out surveillance for nosocomial infections caused by resistant bacteria within UAB Hospital. Major ongoing research efforts include studies of interactions between BV and risk for other STDs; characterization of the make-up and shifts in normal vaginal flora in women; prevention of recurrent BV; and the epidemiology and optimal management strategies for trichomoniasis in males. Her research is funded through the UAB STD CRC (E.W. Hook, PI, J.R. Schwebke Co-PI); and 3 funded RO-1 grants (J.R. Schwebke, P.I.).
- Forums
- ASX - By Stock
- BV article
Dr. Schwebke’s laboratory has emphasized microbiologic studies...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.67M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.7¢ | $257.5K | 2.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 119243 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 60378 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 119243 | 0.086 |
1 | 70000 | 0.085 |
1 | 100000 | 0.084 |
1 | 100000 | 0.082 |
3 | 46938 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 60378 | 1 |
0.090 | 20000 | 1 |
0.091 | 13576 | 1 |
0.092 | 80903 | 3 |
0.093 | 11500 | 2 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |